Table 5. Bodyweight (baseline, 12 weeks and change from baseline).

	n	Bodyweight (kg)
		0 weeks	12 weeks	P (12 weeks vs 0 weeks)
Patients with sulfonylurea dose reduction	66	62.15 ± 15.00	61.75 ± 14.86	<0.05
Patients without sulfonylurea dose reduction	442	63.59 ± 12.89	63.75 ± 13.07	NS
Total	508	63.43 ± 13.22	63.48 ± 13.35	NS

NS, not significant.